Evoke Pharma Inc

Ownership Transactions Reported by 12 Insiders

Symbol
EVOK on Nasdaq
Location
420 Stevens Avenue, Suite 230, Solana Beach, CA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Evoke Pharma Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nantahala Capital Management, LLC 10%+ Owner Nov 6, 2024
Mark Kowieski Chief Financial Officer Aug 7, 2024
Benjamin C. Smeal Director Oct 18, 2024
Ann D. Rhoads Director May 5, 2021
Todd C. Brady Director May 22, 2024
David A. Gonyer CEO, Director Feb 8, 2023
S. Reed Director May 22, 2024
Malcolm R. Hill Director May 22, 2024
Marilyn R. Carlson Chief Medical Officer Aug 7, 2024
Matthew J. D'Onofrio Chief Executive Officer, Director Aug 7, 2024
Cam L. Garner Director May 22, 2024
Widder Kenneth J Director May 22, 2024

Recent Insider Transactions by Companies or Individuals for Evoke Pharma Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.